Current Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 2
Author(s): Tetsumei Urano
Affiliation:
Export Options
About this article
Cite this article as:
Urano Tetsumei, Meet Our Editorial Board Member, Current Drug Targets 2017; 18 (2) . https://dx.doi.org/10.2174/138945011802161229204104
DOI https://dx.doi.org/10.2174/138945011802161229204104 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers